{"id":397511,"date":"2020-12-10T10:03:13","date_gmt":"2020-12-10T15:03:13","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=397511"},"modified":"2020-12-10T10:03:13","modified_gmt":"2020-12-10T15:03:13","slug":"nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/","title":{"rendered":"NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">NEW YORK<\/span>, <span class=\"xn-chron\">Dec. 10, 2020<\/span> \/PRNewswire\/ &#8212; Attorney Advertising &#8212;\u00a0Bronstein, Gewirtz &amp; Grossman, LLC reminds investors that a class action lawsuit has been filed against Minerva Neurosciences, Inc.\u00a0\u00a0(&#8220;Minerva&#8221; or &#8220;the Company&#8221;) (NASDAQ: NERV)\u00a0and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Minerva\u00a0securities between\u00a0May 15, 2017 and <span class=\"xn-chron\">November 30<\/span>, 2020,\u00a0both dates inclusive (the &#8220;Class Period&#8221;).\u00a0\u00a0Such investors are encouraged to join this case by visiting the firm&#8217;s site: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007848-1&amp;h=3256345386&amp;u=http%3A%2F%2Fwww.bgandg.com%2Fnerv&amp;a=www.bgandg.com%2Fnerv\" rel=\"nofollow noopener noreferrer\">www.bgandg.com\/nerv<\/a>.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\" title=\"Bronstein, Gewirtz &amp; Grossman, LLC\" alt=\"Bronstein, Gewirtz &amp; Grossman, LLC\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.\u00a0<\/b>\n      <\/p>\n<p>The Complaint alleges that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that:\u00a0(1) the truth about the feedback received from the FDA concerning the &#8220;end-of-Phase 2&#8221; meeting; (2) the Phase <span class=\"xn-money\">2b<\/span> study did not use the commercial formulation of roluperidone and was conducted solely outside of <span class=\"xn-location\">the United States<\/span>; (3) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (4) the Company&#8217;s plan to use the combination of the Phase <span class=\"xn-money\">2b<\/span> and Phase 3 studies would be &#8220;highly unlikely&#8221; to support the submission of an NDA; (5) reliance on these two trials in the submission of an NDA would lead to &#8220;substantial review issues&#8221; because the trials were inadequate and not well-controlled; and (6) as a result, the Minerva&#8217;s public statements were materially false and misleading at all relevant times.<\/p>\n<p>A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm&#8217;s site: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007848-1&amp;h=3256345386&amp;u=http%3A%2F%2Fwww.bgandg.com%2Fnerv&amp;a=www.bgandg.com%2Fnerv\" rel=\"nofollow noopener noreferrer\">www.bgandg.com\/nerv<\/a>\u00a0or you may contact <span class=\"xn-person\">Peretz Bronstein, Esq.<\/span> or his Investor Relations Analyst, <span class=\"xn-person\">Yael Hurwitz<\/span> of Bronstein, Gewirtz &amp; Grossman, LLC at 212-697-6484. If you suffered a loss in Minerva\u00a0you have until <span class=\"xn-chron\">February 8, 2021<\/span> to request that the Court appoint you as lead plaintiff.\u00a0 Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p>Bronstein, Gewirtz &amp; Grossman, LLC is a corporate litigation boutique.\u00a0 Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.\u00a0 In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm&#8217;s expertise includes general corporate and commercial litigation, as well as securities arbitration.\u00a0 \u00a0Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>Contact:<\/p>\n<p>Bronstein, Gewirtz &amp; Grossman, LLC<br \/><span class=\"xn-person\">Peretz Bronstein<\/span> or <span class=\"xn-person\">Yael Hurwitz<\/span><br \/>212-697-6484 | <a target=\"_blank\" href=\"mailto:info@bgandg.com\" rel=\"nofollow noopener noreferrer\">info@bgandg.com<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC18761&amp;sd=2020-12-10\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/nerv-shareholder-alert-bronstein-gewirtz--grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021-301190216.html\">http:\/\/www.prnewswire.com\/news-releases\/nerv-shareholder-alert-bronstein-gewirtz&#8211;grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021-301190216.html<\/a><\/p>\n<p>SOURCE  Bronstein, Gewirtz &amp; Grossman, LLC<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DC18761&amp;Transmission_Id=202012101000PR_NEWS_USPR_____DC18761&amp;DateId=20201210\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK, Dec. 10, 2020 \/PRNewswire\/ &#8212; Attorney Advertising &#8212;\u00a0Bronstein, Gewirtz &amp; Grossman, LLC reminds investors that a class action lawsuit has been filed against Minerva Neurosciences, Inc.\u00a0\u00a0(&#8220;Minerva&#8221; or &#8220;the Company&#8221;) (NASDAQ: NERV)\u00a0and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Minerva\u00a0securities between\u00a0May 15, 2017 and November 30, 2020,\u00a0both dates inclusive (the &#8220;Class Period&#8221;).\u00a0\u00a0Such investors are encouraged to join this case by visiting the firm&#8217;s site: www.bgandg.com\/nerv.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.\u00a0 The Complaint alleges that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that:\u00a0(1) the truth about &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-397511","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, Dec. 10, 2020 \/PRNewswire\/ &#8212; Attorney Advertising &#8212;\u00a0Bronstein, Gewirtz &amp; Grossman, LLC reminds investors that a class action lawsuit has been filed against Minerva Neurosciences, Inc.\u00a0\u00a0(&#8220;Minerva&#8221; or &#8220;the Company&#8221;) (NASDAQ: NERV)\u00a0and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Minerva\u00a0securities between\u00a0May 15, 2017 and November 30, 2020,\u00a0both dates inclusive (the &#8220;Class Period&#8221;).\u00a0\u00a0Such investors are encouraged to join this case by visiting the firm&#8217;s site: www.bgandg.com\/nerv.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.\u00a0 The Complaint alleges that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that:\u00a0(1) the truth about &hellip; Continue reading &quot;NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-10T15:03:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021\",\"datePublished\":\"2020-12-10T15:03:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\\\/\"},\"wordCount\":455,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/439152\\\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\\\/\",\"name\":\"NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/439152\\\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\",\"datePublished\":\"2020-12-10T15:03:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/439152\\\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/439152\\\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/","og_locale":"en_US","og_type":"article","og_title":"NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021 - Market Newsdesk","og_description":"PR Newswire NEW YORK, Dec. 10, 2020 \/PRNewswire\/ &#8212; Attorney Advertising &#8212;\u00a0Bronstein, Gewirtz &amp; Grossman, LLC reminds investors that a class action lawsuit has been filed against Minerva Neurosciences, Inc.\u00a0\u00a0(&#8220;Minerva&#8221; or &#8220;the Company&#8221;) (NASDAQ: NERV)\u00a0and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Minerva\u00a0securities between\u00a0May 15, 2017 and November 30, 2020,\u00a0both dates inclusive (the &#8220;Class Period&#8221;).\u00a0\u00a0Such investors are encouraged to join this case by visiting the firm&#8217;s site: www.bgandg.com\/nerv.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.\u00a0 The Complaint alleges that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that:\u00a0(1) the truth about &hellip; Continue reading \"NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-10T15:03:13+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021","datePublished":"2020-12-10T15:03:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/"},"wordCount":455,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/","name":"NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg","datePublished":"2020-12-10T15:03:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/439152\/Bronstein_Gewirtz_and_Grossman_LLC_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nerv-shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-minerva-neurosciences-inc-shareholders-of-class-action-and-lead-plaintiff-deadline-february-8-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NERV Shareholder Alert: Bronstein, Gewirtz &amp; Grossman, LLC Notifies Minerva Neurosciences, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: February 8, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=397511"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397511\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=397511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=397511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=397511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}